Keyphrases
Cirrhosis
28%
Multimodal Education
28%
COVID-19 Pandemic
28%
Phosphatidylethanol
28%
Abbreviated MRI
28%
Hospitalized Patients
28%
COVID-19
28%
Alcohol Use Disorder Treatment
28%
Alcoholic Liver Disease
28%
Alcohol Use Disorder
28%
Brief Intervention
28%
Treatment Access
28%
Tokyo Guidelines
28%
Charcot's Triad
28%
Metabolic-associated Fatty Liver Disease (MAFLD)
28%
Hepatocellular Carcinoma Surveillance
28%
Non-invasive Test
28%
Fibrosis-4 (FIB-4)
28%
Cost-utility Analysis
28%
Elastography
24%
Liver Disease
12%
YouTube Videos
11%
Academic Websites
11%
Hospitalization
10%
30-day Readmission
10%
In-hospital Mortality
9%
Transplant Hepatologist
9%
Readability Level
9%
Transplant-free Survival
8%
Single Center
7%
Chart Analysis
7%
Endoscopic Retrograde
7%
Altered Sensorium
7%
Essential Diagnostics
7%
Acute Cholangitis
7%
Body Mass Index
6%
Patients with Diabetes
6%
Thailand
6%
Metabolic Traits
6%
DISCERN Score
5%
PEMAT
5%
Internet Browser
5%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cirrhosis
100%
Liver Disease
64%
Liver Cell Carcinoma
57%
Disease
57%
Combination Therapy
43%
Hepatic Encephalopathy
28%
Pandemic
28%
Coronavirinae
28%
Head and Neck Cancer
28%
Recurrent Disease
28%
Fibrosis
28%
Alpha Fetoprotein
16%
Cohort Study
10%
Rifaximin
9%
Placebo
7%
Citalopram
7%
Randomized Controlled Trial
7%
Medicine and Dentistry
Liver Cirrhosis
69%
Liver Disease
33%
Combination Therapy
31%
Chronic Liver Disease
28%
Hepatocellular Carcinoma
28%
Hepatic Encephalopathy
28%
Alcohol Consumption
28%
Health Care Cost
28%
Magnetic Resonance Imaging
28%
Alcoholic Polyneuropathy
28%
Charcot's Triad
28%
Metabolic Dysfunction-Associated Steatotic Liver Disease
28%
Transplantation
14%
Echography
11%
Cost-Effectiveness Analysis
11%
Alpha-Fetoprotein
9%
Rifaximin
9%
Quality Adjusted Life Year
7%
Cohort Analysis
7%
Scoring System
7%
Self Report
5%